Why the study?
Little is known regarding how the etiology and initial presentation of cardiogenic shock, along with preexisting cardiopulmonary remodeling, determine the benefit of transcatheter edge-to-edge repair.
Transcatheter edge-to-edge repair may be a viable option to stabilize patients with cardiogenic shock secondary to acute nonischemic mitral regurgitation.
May offer bailout option in prohibitive-risk cardiogenic shock; hypothesis-generating and should not yet change practice.
Cardiogenic shock secondary from severe mitral valve (MV) regurgitation remains one of the most serious entities in clinical practice, with high mortality and limited options.1 Data from case series and retrospective studies show that transcatheter therapy is an acceptable alternative approach if the risk of surgical options is prohibitive.1,2 The etiology and initial presentation of cardiogenic shock as well as the extent of preexisting cardiopulmonary remodeling are critical determinants of the benefit of transcatheter edge-to-edge repair, albeit little is known in this regard.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: